Login / Signup

Estimating the Prevalence of Using Suspected Counterfeit Medications in the General Population.

Jennifer S JewellElizabeth A BemisJoshua C Black
Published in: Journal of addiction medicine (2024)
These data show the scale of the issue in relation to other well established drug use data points in the US. System-level methods, such as drug scanning software, should be implemented to reduce the likelihood that counterfeit drugs end up in the hands of individuals.
Keyphrases
  • electronic health record
  • big data
  • data analysis
  • risk factors
  • pulmonary embolism
  • high resolution
  • emergency department
  • drug induced
  • machine learning
  • mass spectrometry
  • artificial intelligence